In Diabetes Eglucent Kwikpen is a modern, rapid-acting form of insulin that helps to control high blood glucose (sugar) levels. It replaces the insulin that is normally produced in the body. This helps the glucose get into your cells so your body can use it for energy. It begins to lower your blood glucose level within 10-20 minutes of injecting it and the effect can last for 3-5 hours. You will need to learn exactly how, where, and when to inject this medicine for it to be most effective. Lowering blood glucose levels helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with Eglucent Kwikpen.
Eglucent Kwikpen is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Eglucent Kwikpen is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Eglucent Kwikpen should be used with caution in patients with kidney disease. Dose adjustment of Eglucent Kwikpen may be needed. Please consult your doctor. Frequent and regular monitoring of blood glucose levels is advised for dose adjustment.
Eglucent Kwikpen should be used with caution in patients with liver disease. Dose adjustment of Eglucent Kwikpen may be needed. Please consult your doctor. Frequent and regular monitoring of blood glucose levels is advised for dose adjustment.
If you have missed a dose of Eglucent Kwikpen, your blood sugar level may become too high (hyperglycemia). Check your blood sugar and then take the next dose accordingly.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Eli Lilly and Company India Pvt Ltd || ₹14.5/tablet (25% cheaper)